NO891114L - Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.Info
- Publication number
- NO891114L NO891114L NO89891114A NO891114A NO891114L NO 891114 L NO891114 L NO 891114L NO 89891114 A NO89891114 A NO 89891114A NO 891114 A NO891114 A NO 891114A NO 891114 L NO891114 L NO 891114L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- acid derivatives
- therapeutic active
- analogy procedure
- arakidonic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
- C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
- C07C45/565—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17051288A | 1988-03-21 | 1988-03-21 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO891114D0 NO891114D0 (no) | 1989-03-15 |
NO891114L true NO891114L (no) | 1989-09-22 |
NO169648B NO169648B (no) | 1992-04-13 |
NO169648C NO169648C (no) | 1992-07-22 |
Family
ID=22620151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO891114A NO169648C (no) | 1988-03-21 | 1989-03-15 | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0334119B1 (no) |
JP (1) | JPH024729A (no) |
KR (1) | KR890014514A (no) |
AU (1) | AU628324B2 (no) |
DD (1) | DD283602A5 (no) |
DE (1) | DE68907095T2 (no) |
DK (1) | DK134489A (no) |
ES (1) | ES2056983T3 (no) |
FI (1) | FI891295A (no) |
HU (2) | HU207858B (no) |
IL (1) | IL89666A0 (no) |
NO (1) | NO169648C (no) |
NZ (1) | NZ228410A (no) |
PH (1) | PH26928A (no) |
PT (1) | PT90066B (no) |
ZA (1) | ZA892086B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3499553B2 (ja) * | 1992-02-11 | 2004-02-23 | アラーガン、インコーポレイテッド | レチノイド様生物学的活性を有するヘテロアリール置換フェニルエテニル化合物 |
DE69301894T2 (de) * | 1992-10-28 | 1996-11-07 | Shionogi & Co | Benzylidenderivate |
ES2087019B1 (es) * | 1994-02-08 | 1997-03-16 | Bobel246 S L | Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la 5-lipoxigenasa. |
TW544448B (en) | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
US6376524B1 (en) * | 2000-06-21 | 2002-04-23 | Sunesis Pharmaceuticals, Inc. | Triphenyl compounds as interleukin-4 antagonists |
KR100836207B1 (ko) | 2001-01-18 | 2008-06-09 | 웰리켐 바이오 테크 인크. | 면역 질환 치료용의 신규한 1,2-디페닐에텐 유도체 |
US20030073712A1 (en) | 2001-07-23 | 2003-04-17 | Bing Wang | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
CA2551567C (en) | 2003-12-23 | 2014-04-29 | Abraxis Bioscience, Inc. | Propofol analogs, process for their preparation, and methods of use |
WO2006078941A2 (en) * | 2005-01-20 | 2006-07-27 | Sirtris Pharmaceuticals, Inc. | Novel sirtuin activating compounds and methods of use thereof |
IL274439B2 (en) | 2017-11-10 | 2023-12-01 | Dermavant Sciences GmbH | Process for preparing tapinarof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3188315A (en) * | 1960-05-18 | 1965-06-08 | Schering Corp | Novel compounds for lowering blood cholesterol levels |
FR1390978A (fr) * | 1963-11-20 | 1965-03-05 | Ind Chimique Sa | Procédé de préparation de l'alpha-(thiényl-2) 4-hydroxystilbène et de quelques dérivés et produits obtenus |
US4758586A (en) * | 1985-02-01 | 1988-07-19 | Usv Pharmaceutical Corp. | Indolyl compounds and hyposensitivity use thereof |
DE3602473A1 (de) * | 1986-01-28 | 1987-07-30 | Basf Ag | Vinylphenolderivate, ihre herstellung und verwendung |
US4743606A (en) * | 1986-03-25 | 1988-05-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine having anti-inflammatory and anti-arthritic properties |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
CA1338645C (en) * | 1987-01-06 | 1996-10-15 | George R. Pettit | Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins" |
-
1989
- 1989-03-10 DE DE89104251T patent/DE68907095T2/de not_active Expired - Fee Related
- 1989-03-10 ES ES89104251T patent/ES2056983T3/es not_active Expired - Lifetime
- 1989-03-10 EP EP89104251A patent/EP0334119B1/en not_active Expired - Lifetime
- 1989-03-15 NO NO891114A patent/NO169648C/no unknown
- 1989-03-20 HU HU891323A patent/HU207858B/hu not_active IP Right Cessation
- 1989-03-20 NZ NZ228410A patent/NZ228410A/xx unknown
- 1989-03-20 ZA ZA892086A patent/ZA892086B/xx unknown
- 1989-03-20 FI FI891295A patent/FI891295A/fi not_active Application Discontinuation
- 1989-03-20 DK DK134489A patent/DK134489A/da not_active Application Discontinuation
- 1989-03-20 DD DD89326756A patent/DD283602A5/de not_active IP Right Cessation
- 1989-03-20 JP JP1069109A patent/JPH024729A/ja active Pending
- 1989-03-20 AU AU31514/89A patent/AU628324B2/en not_active Ceased
- 1989-03-20 IL IL89666A patent/IL89666A0/xx unknown
- 1989-03-20 HU HU9201174A patent/HU9201174D0/hu active Pending
- 1989-03-20 KR KR1019890003422A patent/KR890014514A/ko not_active Application Discontinuation
- 1989-03-21 PT PT90066A patent/PT90066B/pt not_active IP Right Cessation
- 1989-03-21 PH PH38366A patent/PH26928A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0334119B1 (en) | 1993-06-16 |
PT90066A (pt) | 1989-11-10 |
EP0334119A1 (en) | 1989-09-27 |
DK134489A (da) | 1989-09-22 |
AU628324B2 (en) | 1992-09-17 |
FI891295A0 (fi) | 1989-03-20 |
DE68907095T2 (de) | 1994-01-05 |
NO169648C (no) | 1992-07-22 |
DK134489D0 (da) | 1989-03-20 |
PH26928A (en) | 1992-12-03 |
HU207858B (en) | 1993-06-28 |
NO169648B (no) | 1992-04-13 |
DE68907095D1 (de) | 1993-07-22 |
NO891114D0 (no) | 1989-03-15 |
KR890014514A (ko) | 1989-10-24 |
DD283602A5 (de) | 1990-10-17 |
JPH024729A (ja) | 1990-01-09 |
ZA892086B (en) | 1990-11-28 |
AU3151489A (en) | 1989-09-21 |
FI891295A (fi) | 1989-09-22 |
ES2056983T3 (es) | 1994-10-16 |
PT90066B (pt) | 1994-05-31 |
NZ228410A (en) | 1993-08-26 |
HUT50093A (en) | 1989-12-28 |
HU9201174D0 (en) | 1992-07-28 |
IL89666A0 (en) | 1989-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
NO871266D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
NO870049L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO890155D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO166130C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater. | |
NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO891114D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
NO168825C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater | |
NO890724L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. |